I-Mab Files Investor Presentation for June 2025
Ticker: NBP · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1778016
| Field | Detail |
|---|---|
| Company | I-Mab (NBP) |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: investor-relations, presentation
TL;DR
I-Mab dropped a new investor deck on 6/2/25 - check it for updates.
AI Summary
I-Mab filed a Form 6-K on June 2, 2025, to report an investor presentation dated June 2, 2025. The filing includes Exhibit 99.1, which is the investor presentation itself. The company's principal executive offices are located at 2440 Research Boulevard, Suite 400, Rockville, MD 20850.
Why It Matters
This filing provides investors with updated information and strategic insights directly from the company, potentially influencing investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine submission of an investor presentation and does not contain significant new financial or operational disclosures that would inherently increase risk.
Key Players & Entities
- I-Mab (company) — Filer of the 6-K report
- June 2, 2025 (date) — Date of the investor presentation and filing
- 2440 Research Boulevard, Suite 400, Rockville, MD 20850 (location) — Principal executive offices of I-Mab
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report an investor presentation dated June 2, 2025, as Exhibit 99.1.
When was the investor presentation filed?
The investor presentation was filed on June 2, 2025.
Where are I-Mab's principal executive offices located?
I-Mab's principal executive offices are located at 2440 Research Boulevard, Suite 400, Rockville, MD 20850.
Does I-Mab file annual reports under Form 20-F or Form 40-F?
I-Mab indicates that it files annual reports under cover of Form 20-F.
What exhibit number is associated with the investor presentation?
The investor presentation is filed as Exhibit No. 99.1.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding I-Mab (NBP).